These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 27237318)
1. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown. Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318 [TBL] [Abstract][Full Text] [Related]
2. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525 [TBL] [Abstract][Full Text] [Related]
3. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells. Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353 [TBL] [Abstract][Full Text] [Related]
4. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity. Lin TC; Chen ST; Huang MC; Huang J; Hsu CL; Juan HF; Lin HH; Chen CH Oncotarget; 2017 Jun; 8(26):42588-42601. PubMed ID: 28388560 [TBL] [Abstract][Full Text] [Related]
5. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway. Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438 [TBL] [Abstract][Full Text] [Related]
7. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M. Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179 [TBL] [Abstract][Full Text] [Related]
8. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314 [TBL] [Abstract][Full Text] [Related]
9. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition. Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670 [TBL] [Abstract][Full Text] [Related]
10. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Rachagani S; Macha MA; Ponnusamy MP; Haridas D; Kaur S; Jain M; Batra SK Carcinogenesis; 2012 Oct; 33(10):1953-64. PubMed ID: 22791819 [TBL] [Abstract][Full Text] [Related]
11. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis. Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869 [TBL] [Abstract][Full Text] [Related]
12. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth. Kimura R; Yoshimaru T; Matsushita Y; Matsuo T; Ono M; Park JH; Sasa M; Miyoshi Y; Nakamura Y; Katagiri T Int J Oncol; 2020 Feb; 56(2):581-595. PubMed ID: 31894262 [TBL] [Abstract][Full Text] [Related]
13. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1. Gao F; Zheng G Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886 [TBL] [Abstract][Full Text] [Related]
14. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683 [TBL] [Abstract][Full Text] [Related]
15. Polypeptide Guo Y; Shi J; Zhang J; Li H; Liu B; Guo H Onco Targets Ther; 2017; 10():3337-3344. PubMed ID: 28744137 [TBL] [Abstract][Full Text] [Related]
16. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression. Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912 [TBL] [Abstract][Full Text] [Related]
17. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. Wang F; Sloss C; Zhang X; Lee SW; Cusack JC Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687 [TBL] [Abstract][Full Text] [Related]
18. Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells. Li Y; Wu C; Chen T; Zhang J; Liu G; Pu Y; Zhu J; Shen C; Zhang Y; Zeng N; Zhang X Oncol Rep; 2016 Dec; 36(6):3449-3455. PubMed ID: 27748843 [TBL] [Abstract][Full Text] [Related]
19. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78. Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740 [TBL] [Abstract][Full Text] [Related]
20. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]